Executive moves abound in the CRO world this month; plus a list of the 2015 RAPS Fellows.
Quintiles Founder Dr. Dennis Gillings, CBE, will retire from his position as Executive Chairman of Quintiles at the end of this year. Gillings will remain on the Board as a director. The Board has appointed Jack M. Greenberg to serve as Chairman of the Board, effective January 1, 2016.
Quintiles also announced that Kevin Gordon, currently serving as Executive Vice President, Operations and Chief Financial Officer (CFO), has been promoted to Chief Operating Officer (COO). In addition, Michael McDonnell will join Quintiles next month as Executive Vice President, Chief Financial Officer (CFO).
Catalent Pharma Solutions announced that Wetteny Joseph has been appointed as its new President, Clinical Supply Services. Joseph first joined Catalent in 2008 as Corporate Controller, and in 2012, was charged with leading the finance function for the company’s Modified Release Technologies business unit. In 2013, Mr. Joseph was promoted to Vice President of Finance for Catalent’s Development and Clinical Services division, which included the Clinical Supply Services business unit.
ICON announced two new leadership appointments to its Asia Pacific operations. Mary Pan has been appointed Vice President, Asia Pacific, where she will lead ICON’s continued growth and expansion in the region. Hiroshi Ichikawa has been appointed Vice President and General Manager of ICON’s operations in Japan.
SCORR Marketing, a global marketing and communications firm that specializes in the drug development, health care and life science industries, has announced the appointment of Anne-Marie Hess as senior strategic advisor. Prior to joining SCORR, Hess was the vice president of marketing, corporate communications at InVentiv Health Clinical.
PPD has appointed Yasumasa Kurioka as general manager of PPD-SNBL, the joint venture formed between PPD and Shin Nippon Biomedical Laboratories Ltd., earlier this year. Kurioka most recently served as the senior director, country head of clinical operations in Japan, for another global contract research organization.
Greenphire, a provider of payment technology for the clinical trials industry, announced the appointment of Jim Murphy as CEO. Murphy previously served as president and managing director of Almac Clinical Technologies.
The Regulatory Affairs Professionals Society (RAPS) announced its 2015 class of RAPS Fellows, which recognizes senior regulatory professionals for their continued contributions and leadership toward the advancement of the profession and the professional.
The 2015 RAPS Fellows are:
ClinTec International celebrated an exceptional year of international growth with Glasgow’s Lord Provost, guests, Country Managers and Directors from over 40 countries, at the ClinTec International Global Conference held in Glasgow. ClinTec International was recently recognized as the “UK’s Best Full Service Clinical Research Organization” at the Healthcare & Pharmaceuticals Awards 2015, organized by Global Health & Pharma. This sits alongside the previously received Queens Award for Enterprise and the 2015 Business Woman of the Year at the Glasgow Business Awards.
PPD’s, Senior Vice President of Global Quality and Compliance Jay Dixon has been elected to the board of directors of the North Carolina Biosciences Organization (NCBIO), the trade association for the state’s bioscience industry. Dixon joins 14 bioscience industry leaders who were elected or re-elected to the NCBIO board. Board terms are three years.
Veeva Systems’ Vice President of Veeva Vault, Jennifer Goldsmith, has been appointed to the Board of Editors for Regulatory Focus, the flagship online publication of the Regulatory Affairs Professionals Society.
How Digital Technology and Remote Assessment Strategies Can Aid Clinical Trial Research
July 24th 2020While there's been hopeful news on treatments and vaccines, sponsors should plan to discuss necessary strategies and contingencies at the outset of new studies or re-opening of halted studies during the COVID-19 pandemic.